` Comparison: 000952 vs ROG - Alpha Spread

000952
vs
ROG

Over the past 12 months, Hubei Guangji Pharmaceutical Co Ltd has outperformed ROG, delivering a return of +39% compared to the ROG's +25% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
000952
ROG
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Intrinsic Value
5.81 CNY
Overvaluation 26%
Intrinsic Value
Price
ROG Intrinsic Value
406.57 CHF
Undervaluation 8%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
7.9 CNY
Roche Holding AG
SIX:ROG
373.8 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
000952, ROG

000952
ROG
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Hubei Guangji Pharmaceutical Co Ltd
Revenue
Roche Holding AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
000952, ROG

000952
ROG
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
Roche Holding AG
SIX:ROG
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Hubei Guangji Pharmaceutical Co Ltd
20%
ROG
73.9%

Operating Margin

Hubei Guangji Pharmaceutical Co Ltd
-32.1%
ROG
33.8%

Net Margin

Hubei Guangji Pharmaceutical Co Ltd
-38.6%
ROG
15.3%

FCF Margin

Hubei Guangji Pharmaceutical Co Ltd
3.2%
ROG
21.4%

ROE

Hubei Guangji Pharmaceutical Co Ltd
-21.4%
ROG
32.7%

ROA

Hubei Guangji Pharmaceutical Co Ltd
-7.7%
ROG
9.9%

ROIC

Hubei Guangji Pharmaceutical Co Ltd
-7.8%
ROG
19.3%

ROCE

Hubei Guangji Pharmaceutical Co Ltd
-11.4%
ROG
30.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
000952, ROG

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
000952, ROG

Loading
000952
ROG
Difference
www.alphaspread.com

Performance By Year
000952, ROG

Loading
000952
ROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 000952 to other stocks
LLY
Eli Lilly and Co
JNJ
Johnson & Johnson
AZN
AstraZeneca PLC
NOVN
Novartis AG
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett